Massage as an Adjunct Approach to Care for Pregnant Women Who Have Experienced a Stillbirth

February 24, 2025 updated by: Sarah Fogarty, Fogarty Sarah

Mixed-methods Single-arm Study Evaluating the Feasibility of Massage as an Adjunct Approach to Care for Pregnant Women Who Have Experienced a Stillbirth

The goal of this mixed-methods single-arm study is to measure the feasibility of massage as an adjunct approach to care for pregnant women who have experienced a stillbirth. In order to provide pilot data, this intervention study will:

  1. Determine the feasibility and acceptability of the massage intervention and optimize the timing and outcome measures,
  2. Provide data for future use in an individual participant data systematic review, and
  3. Evaluate experiences of women undertaking the intervention

Participants will [ If there is a comparison group: Researchers will compare [insert groups] to see if [insert effects].

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Research shows that women experiencing pregnancy after stillbirth experience anxiety, fear, and depression. There is a limited evidence of adjunct emotional care approaches for women to utilise to help manage pregnancy after a stillbirth. Massage may assist women who are pregnant after a stillbirth via decreasing anxiety, worry and stress.

Aim: To measure the feasibility of massage as an adjunct approach to care for pregnant women who have experienced a stillbirth.

Design: This study will use a convergent parallel mixed-methods, single arm repeated measures pilot trial design.

Setting: Massage therapists' private clinics across Australia. Participants: Subjects will include 75 pregnant women who have experienced a stillbirth in a previous pregnancy.

Intervention: Women will receive four massages within a four-month period at intervals of their choosing. The massage treatments are based on a vulnerability-to-stress concept which acknowledges the impact of stress on a pregnant woman based on a biopsychosocial model.

The massage protocol allows treatment to be individualised to meet the needs of the participant.

Main outcome measures: The primary outcomes are a) feasibility, b) acceptability and experience of the massage intervention and c) optimization - i.e., capacity of the outcome measures to capture the impact of the intervention received, and to determine when treatments are likely to be of most value.

Analysis Plan: Data will be analysed to meet the study objectives of determining feasibility, acceptability, optimising timing, and outcome measures, and to obtain preliminary data to understand the effects and value of massage on women who are pregnant after a stillbirth.

Significance of the work: Standard antenatal care is emotionally unsuitable for many women in pregnancies following a stillbirth and there is a lack of direct evidence on what interventions or approaches to care might benefit these women. Our proposed research will begin to address this lack of direct evidence.

Study Type

Interventional

Enrollment (Actual)

76

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New South Wales
      • Sydney, New South Wales, Australia, 2000
        • Western Sydney University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Pregnant women 18 years of age or greater who have experienced a stillbirth (pregnancy loss from 20 weeks gestation) in a previous pregnancy.
  • Participants who had a medial termination from 20-weeks' gestation will be included in the study.
  • Participants must be able to attend one of the study pregnancy massage therapists' clinics located within Australia.
  • Having had previous massage experience is not an enrolment criterion, it is just not an exclusion criterion.

Exclusion Criteria:

- Participants will be excluded if they are unable to receive the study treatments in the allocated time frame.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Massage
Women will receive four 60 minute massage consultations within a four-month period at intervals of their choosing.
Individualised treatment using massage techniques such as longitudinal gliding, transverse gliding, digital ischemic pressure, transverse frictions, and transverse gliding.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To assess the feasibility of massage as an adjunct approach to care for pregnant women who have experienced a stillbirth as assessed using a mixed methods narrative and joint display approach
Time Frame: 1 year
The quantitative and qualitative findings will be integrated using a narrative reporting approach and fit of data integration (coherence of the quantitative and qualitative findings) will be reported.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Elucidating participants' experience of massage in a pregnancy after a stillbirth using a qualitative in-depth interview
Time Frame: Through study completion, an average of 1 year
Thematic inductive analysis will be used to analyse the qualitative data
Through study completion, an average of 1 year
Changes in worry from baseline to a week post treatment interventions using the self-reported Cambridge Worry Score
Time Frame: Through study completion, an average of 1 year
Higher scores indicate greater worry. Scores from 0-85
Through study completion, an average of 1 year
Changes in maternal anxiety symptoms from baseline to a week post treatment interventions using the Generalized Anxiety Disorder Assessment 7
Time Frame: Through study completion, an average of 1 year
Higher scores indicate greater anxiety. Min score is 0 and max is 21.
Through study completion, an average of 1 year
Changes in coping from baseline to a week post treatment interventions using the self-reported Revised Prenatal Coping Inventory
Time Frame: Through study completion, an average of 1 year
Higher scale scores correspond to a more frequent use of the specific coping style.
Through study completion, an average of 1 year
Changes in self-efficacy from baseline to a week post treatment interventions using the Strategies Used by People to Promote Health measure
Time Frame: Through study completion, an average of 1 year
Higher scores indicate greater confidence in carrying out the behaviors to promote health. Total score range is from 29 to 145.
Through study completion, an average of 1 year
Changes in maternal stress symptoms from baseline to a week post treatment interventions using the Perceived Stress Scale
Time Frame: Through study completion, an average of 1 year
Higher scores indicating higher perceived stress. The total score range is from zero to 40 with a scores ranging from 0-13 considered low stress, 14-26 moderate stress and 27-40 high stress.
Through study completion, an average of 1 year
Assessing empathy in the context of the therapeutic relationship via the Consultation and Relational Empathy patient-reported experience measure
Time Frame: Through study completion, an average of 1 year
This scale has 10 items that measures patients' perceptions of relational empathy in the consultation. The total score range is from 10 to 40 with higher scores indicating greater perceived relational empathy.
Through study completion, an average of 1 year
Recruitment rates (proportion of people randomised/proportion of people eligible)
Time Frame: Through study completion, an average of 1 year
Presented as numbers and percentages
Through study completion, an average of 1 year
Retention rates (proportion of people providing the outcomes of interest/proportion randomised)
Time Frame: Through study completion, an average of 1 year
Presented as numbers and percentages
Through study completion, an average of 1 year
Compliance with completing the validated outcome measures (number of validated measures asked to complete/number of validated measures completed)
Time Frame: Through study completion, an average of 1 year
Presented as numbers and percentages
Through study completion, an average of 1 year
Optimization of massage timing to determine when treatments are likely to be of most value presented as a average of time between treatments
Time Frame: Through study completion, an average of 1 year
Presented as means and ranges of times between treatments
Through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Sarah Fogarty, PhD, Western Sydney University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 7, 2023

Primary Completion (Actual)

August 1, 2024

Study Completion (Actual)

December 31, 2024

Study Registration Dates

First Submitted

November 11, 2022

First Submitted That Met QC Criteria

November 23, 2022

First Posted (Actual)

December 5, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 24, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All individual participant data that underlie results in a publication. The stored data available for re-use will not have information in it that makes participants identifiable.

IPD Sharing Time Frame

Data collected from this study will be made available online and world-wide in perpetuity.

IPD Sharing Access Criteria

None, it will be open access.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe